Pfizer Phase 3 Respiratory Syncytial Virus (RSV) Clinical Trial

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Respiratory Syncytial Virus
  • Age: Between 18 years - 110 years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    We are enrolling two substudy groups based on participant medical history.
      Substudy A: Adults between 18-59 years who meet ONE OR BOTH of the following criteria:
    1. Currently living with one or more chronic health disorders (can include pulmonary, cardiovascular, renal, hepatic, neurologic, hematologic, and/or metabolic disorders) for more than 6 months; OR
    2. Currently living in a nursing home or other-long term care facility.
      Substudy B: Adults over 18 years, who meet ONE of the following criteria:
    1. Currently in treatment for advanced NSCLC; OR
    2. Currently undergoing maintenance hemodialysis secondary to endstage renal disease; OR
    3. Currently on active immunomodulator therapy; OR
    4. Received a kidney, liver, lung, or heart transplant at least 3 months ago.

You may not be eligible for this study if the following are true:

    1. Substudy A:
    2. History of isolated hypertension; AND/OR
    3. Significant change to your chronic disease therapy in the past 6 weeks; AND/OR
    4. Hospitalization in the 12 weeks before the study.
      Substudy B:
    1. Receipt or planned receipt of blood/plasma products or immunoglobulin 60 days before and during the course of the study.
    2. History of transplant rejection or treatment for rejection within 3 months before study.



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.